Viking Global Investors - Massinvestor Venture Capital and Private Equity Database

HF Viking Global Investors

https://www.vikingglobal.com/

Office Locations:

55 Railroad Ave. #300
Greenwich, CT 06830
Phone: 203-863-5000

Get all office locations for this firm with a National Database subscription or New York Database subscription.

Stages:

Early
Middle Market

Industries:

Financial Services

Food & Agriculture

Life Sciences & Healthcare

Description:

Viking Global Investors LP is a global investment firm founded in 1999. The firm manages approximately $50 billion of capital for our investors. Viking has offices in Greenwich, New York, Hong Kong, London and San Francisco and is registered as an investment adviser with the U.S. Securities and Exchange Commission. The firm uses fundamental analysis to select investments, primarily public and private equity interests, across industries and geographies. Viking generally invests in companies based on a thorough assessment of their business models and fundamentals, the quality of their management teams and cyclical and secular industry trends.

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

Investment Firm Key

   VC = Venture Capital
   PE = Private Equity
   A = Angel
   I = Incubator
   MB = Merchant Bank
   VD = Venture Debt
   FI = Family Investment Office
   FOF = Fund of Funds
   ED = Economic Development Office
   TT = Technology Transfer Office
   CVC = Corporate Venture Capital
   SEC = Secondary Purchaser
   HF = Hedge Fund/Mutual Fund

COMPANY STAGE	REVENUE
Venture Capital
Seed Stage (includes "pre-seed," or concept stage)	No Revenue
Early Stage	Minimal Revenue
Growth Stage (also called Mid-stage)	$2M-$7M
Expansion Stage (also called Late-stage)	$7M and greater
Private Equity
Lower Middle Market	$10M-$249M
Middle Market	$250M-$499M
Upper Middle Market	$500M-$1B
Large Cap	>$1B

Click Here for a
FREE DEMO
of the #1 VC & PE
Database

▶ 5,000 Firms

▶ 18,000 Partner Emails

▶ 30,000 Portfolio
companies

Investment Team:

Name	Title	Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
David Truetzel	Analyst
Hans Reuter

Recent Funding Events (trailing 12 months):

Date	Name	State	Amount	Stage
04/03/2024	Diagonal Therapeutics	MA	$128,000,000	Series A
03/06/2024	Sionna Therapeutics	MA	$182,000,000	Series C
02/13/2024	Areteia Therapeutics	NC	$75,000,000	Series A
02/08/2024	Neurona Therapeutics	CA	$120,000,000	Venture
01/04/2024	Human Immunology Biosciences	CA	$95,000,000	Series B
12/19/2023	Lightmatter	MA	$155,000,000	Series C-2
10/24/2023	DermBiont	MA	$35,200,000	Series B
09/28/2023	AlphaSense	NY	$150,000,000	Series E
07/16/2023	Allonnia	MA	$30,000,000	Series A Extension
06/07/2023	Ecovative Design	NY	$30,000,000	Series E
05/31/2023	Lightmatter	MA	$154,000,000	Series C
05/08/2023	Solarea Bio	MA	$15,000,000	Series B